Breaking News: AZN – Market Insights, Analysis & Latest Updates

Sweden stocks lower at close of trade; OMX Stockholm 30 down 1.24%

Sweden's OMX Stockholm 30 index fell 1.24% due to declines in key sectors, with notable losses in healthcare and telecom stocks amid rising crude oil and gold prices.

investing.com • 30/10/2024 - 17:00 PM

Roche comes out against allowing takeover of drug manufacturer Catalent

Roche's CEO urged authorities to block Novo Nordisk's acquisition of Catalent, citing potential competition issues in the weight-loss drug market, raising concerns for smaller competitors.

investing.com • 23/10/2024 - 08:41 AM

MBX Biosciences earns Buy rating at three investment firms

Three investment firms have given MBX Biosciences a Buy rating, citing promising treatments and potential catalysts that could significantly boost the company's stock value.

investing.com • 08/10/2024 - 14:34 PM

Cboe to list hedged ADRs developed by Precidian

Precidian Investments introduced hedged ADRs allowing U.S. investors to buy foreign stocks with reduced currency risk, addressing long-standing market needs and enhancing investment tools.

investing.com • 07/10/2024 - 19:26 PM

US will still pay at least twice as much after negotiating drug prices

The U.S. negotiated drug prices under Medicare remain significantly higher than those in other wealthy nations, highlighting disparities in healthcare costs and market dynamics.

investing.com • 03/09/2024 - 10:07 AM

Sweden stocks lower at close of trade; OMX Stockholm 30 down 1.24%

Roche comes out against allowing takeover of drug manufacturer Catalent

MBX Biosciences earns Buy rating at three investment firms

Cboe to list hedged ADRs developed by Precidian

US will still pay at least twice as much after negotiating drug prices

Currency